Logo

pneumonia

Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform

BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.

Sequencing Study Highlights Vaccine-Dodging Streptococcus Pneumoniae Lineage

Researchers turned to whole-genome sequences to characterize S. pneumoniae serotypes that became prominent after the introduction of a pneumococcal conjugate vaccine.

OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
Premium

The company expects the trial results to bolster sales by increasing physician confidence in the panel.

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators.

BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases
Premium

A handful of recently published trials suggest that use of the pneumonia panel could lead to more targeted therapy delivered more quickly than standard methods.

Apr 21, 2020

Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients

Dec 20, 2019

FDA Clears Curetis Lower Respiratory Tract Infections Panel

Jun 10, 2019

Streptococcus Pneumoniae Changes in Response to Vaccine Introduction, Global Genomic Survey Finds

Apr 11, 2019

Curetis 2018 Revenues Grow 17 Percent

Feb 6, 2019

AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests

Feb 4, 2019

Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval

Jan 30, 2019

Curetis Receives Malaysia, Thailand Regulatory Approvals

Dec 13, 2018

Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

Nov 13, 2018

BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

Oct 11, 2018

Curetis Extends Distribution Agreement With Beijing Clear Biotech in China

May 17, 2018

Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test

Apr 19, 2018

BioMérieux Q1 Revenues Up 3 Percent

Apr 4, 2018

Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance

Feb 6, 2018

Curetis Gets Singapore Approval for Pneumonia Test

Jul 31, 2017

IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests

May 12, 2017

Metagenomic Analysis Tool Taxonomer IDs Multiple Pathogens From Clinical Samples

May 11, 2017

With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship
Premium

Oct 26, 2016

Curetis Wraps Up US Clinical Trial for Lower Respiratory Infection Panel; Readies FDA Submission
Premium

Jun 15, 2016

FDA Clears Meridian Bioscience's Updated Mycoplasma Pneumoniae Test

Mar 3, 2016

Curetis Validating Blood Culture Cartridge for CE-IVD Launch in Q2
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.